You are here: Industry Insights > COVID-19

News List

IIIT Delhi offers life-changing solutions against threats posed by COVID-19 vaccine expresspharma
October 10, 2020
The department has also suggested that there is a need to utilise computer-aided techniques for the identification of potential vaccine candidates to fight against COVID-19.
Irisys Signs Contract with TFF Pharma contractpharma
October 10, 2020
?Irisys LLC has announced its third contract for production and manufacturing in partnership with TFF Pharmaceuticals Inc.
Eisai Enters Joint Development Agreement for COVID-19 Therapeutics contractpharma
October 10, 2020
Aims to understand the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the aggravation of COVID-19.
Kindred Bio Expands Agreement with Vaxart contractpharma
October 10, 2020
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.
Rentschler Biopharma Enters COVID-19 Vax Agreement with BioNTech contractpharma
October 10, 2020
?Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has entered an agreement to serve as CDMO partner for BioNTech.
FDA issues guidance on emergency use authorisation for COVID-19 vaccines expresspharma
October 10, 2020
In the case of an investigational vaccine developed for the prevention of COVID-19, both pathways require the submission of data demonstrating any vaccine's safety and effectiveness.
EC signs agreement for additional doses of Gilead’s Covid-19 drug pharmaceutical-technology
October 10, 2020
The European Commission (EC) has inked a joint procurement agreement (JPA) with Gilead Sciences for the supply of up to 500,000 treatment courses of the company’s Covid-19 drug, Veklury (remdesivir).
Eli Lilly seeks EUA for monotherapy against Covid-19 pharmaceutical-technology
October 10, 2020
Eli Lilly has submitted an application to the US Food and Drug Administration (FDA) seeking emergency use authorisation (EUA) for LY-CoV555 monotherapy for treating higher-risk patients with mild-to-moderate Covid-19.
Collectively strengthen pandemic response; plan for COVID-19 vaccination: WHO expresspharma
October 09, 2020
Countries would also need to strengthen vaccine cold chain systems; ensure trained staff perform vigilance activities for vaccine safety.
Eiger Announces Results of Study in Patients with Mild, Uncomplicated COVID-19 americanpharmaceuticalreview
October 09, 2020
Eiger BioPharmaceuticals announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.